Archive BacDiveID:10.13145/bacdive14445.20230509.8.1

Strain identifier

BacDive ID: 14445

Type strain:

Species: Staphylococcus aureus

Strain Designation: 209 P, 209P

Strain history: CIP <- 1953, ATCC <- W.A. Randall, FDA, Washington, USA: strain 209P

NCBI tax ID(s): 1280 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.

General

@ref: 139

BacDive-ID: 14445

DSM-Number: 346

keywords: genome sequence, 16S sequence, Bacteria, facultative anaerobe, mesophilic, Gram-positive, antibiotic resistance, human pathogen

description: Staphylococcus aureus 209 P is a facultative anaerobe, mesophilic, Gram-positive human pathogen that has multiple antibiotic resistances.

NCBI tax id

NCBI tax id: 1280
Matching level: species

strain history

@ref	history
139	<- ATCC <- FDA, 209 P
67770	IAM 12082 <-- IID 671 (strain 209P).
116632	CIP <- 1953, ATCC <- W.A. Randall, FDA, Washington, USA: strain 209P

doi: 10.13145/bacdive14445.20230509.8.1

Name and taxonomic classification

LPSN

@ref: 20215
description: domain/bacteria
keyword: phylum/bacillota
domain: Bacteria
phylum: Bacillota
class: Bacilli
order: Caryophanales
family: Staphylococcaceae
genus: Staphylococcus
species: Staphylococcus aureus
full scientific name: Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Staphylococcus aureus subsp. anaerobius

@ref: 139

domain: Bacteria

phylum: Firmicutes

class: Bacilli

order: Bacillales

family: Staphylococcaceae

genus: Staphylococcus

species: Staphylococcus aureus

full scientific name: Staphylococcus aureus Rosenbach 1884

strain designation: 209 P, 209P

type strain: no

Morphology

cell morphology

@ref	gram stain	confidence	cell shape	motility
69480	positive	100
116632	positive		coccus-shaped	no

colony morphology

@ref	type of hemolysis	hemolysis ability	incubation period
139	beta	1	1-2 days
116632		1

Culture and growth conditions

culture medium

@ref	name	growth	link	composition
139	COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)	yes	https://mediadive.dsmz.de/medium/693	Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
139	TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)	yes	https://mediadive.dsmz.de/medium/92	Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
41865	MEDIUM 3 - Columbia agar	yes		Columbia agar (39.000 g);distilled water (1000.000 ml)
116632	CIP Medium 72	yes	https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72
116632	CIP Medium 3	yes	https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=3

culture temp

@ref	growth	type	temperature	range
139	positive	growth	37	mesophilic
41865	positive	growth	37	mesophilic
67770	positive	growth	37	mesophilic
116632	positive	growth	15-45
116632	no	growth	10	psychrophilic

Physiology and metabolism

oxygen tolerance

@ref: 116632
oxygen tolerance: facultative anaerobe

antibiogram

@ref	medium	Penicillin G	oxacillin	ampicillin	ticarcillin	mezlocillin	cefalotin	cefazolin	cefotaxime	imipenem	tetracycline	chloramphenicol	gentamycin	amikacin	vancomycin	erythromycin	lincomycin	ofloxacin	norfloxacin	pipemidic acid	nitrofurantoin	bacitracin	polymyxin b	kanamycin	neomycin	doxycycline	ceftriaxone	clindamycin	fosfomycin	moxifloxacin	linezolid	nystatin	quinupristin/dalfopristin	teicoplanin	piperacillin/tazobactam	incubation temperature	incubation time	oxygen condition
139	Mueller-Hinton Agar	40	32-34	36-38	42-44	34	40	40	28	50	32-34	30	22	24	20	30	30	28	22-24	8	24	18	8	26	20	34	28	38	36-38	32	30	0	30	20	32-34
139	Mueller-Hinton Agar	40-42	34	38-40	42-44	32-34	40-42	40	30	50	34	30	26	28	20	32	30	30	24-26	10	24-26	18-20	8	28-30	24	36	28-30	38-40	30-32	32	32	0	28-30	20	32-34
139	Mueller-Hinton Agar	44	34-36	40	46	36	44	42-44	34	50	36-38	30	26-28	28	20	32-34	30	30	26	10	26	18	10	30	24	38	30	40	38-40	34-36	40	0	32	20	36	37	1	aerob
139	Mueller-Hinton Agar	42-44	36	40	48	36	44	42	30	50	38	32	26	26-28	20	32	30-32	30	24-26	10	26	20	8	28-30	22	38-40	30	40	38-40	34	40	0	30	20	38	37	1	aerob
139	Mueller-Hinton Agar	28	24	24	32	22	28	26-28	18-20	38	18	16-18	16	20	14	18	18	18	18	0	18	12	0	0	0	18	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	37
139	Mueller-Hinton Agar	40-42	34	36-38	42-44	32	40	40	28	50	32-34	30-32	26	26	20	30-32	28-30	28	24	12	24	18-20	10	34	22	36	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	37
139	Mueller-Hinton Agar	42	34	38-40	42-44	32-34	40-42	38-40	28	46	32	30-32	24	24	20-22	30-32	28-30	28-30	24-26	10	24	16-18	10	28	22	34-36	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	n.d.	37
139	Mueller Hinton	42-44	36	40	48	34-36	42-44	40	28	50	36-38	32	26	26	20-22	32	30	30	26	8	26	20	8	30	22	38-40	30	40	40-42	36	38	0	30	20	36	37		aerob

spore formation

@ref	spore formation	confidence
69481	no	99
69480	no	99.725

metabolite utilization

@ref	Chebi-ID	metabolite	utilization activity	kind of utilization tested
116632	17632	nitrate	+	reduction
116632	16301	nitrite	-	reduction
116632	35020	tributyrin	+	hydrolysis
68375	16199	urea	+	hydrolysis
68375	29016	arginine	+	hydrolysis
68375	18257	ornithine	-	degradation
68375	4853	esculin	-	hydrolysis
68375	17634	D-glucose	+	fermentation
68375	15824	D-fructose	+	fermentation
68375	16024	D-mannose	+	fermentation
68375	17306	maltose	+	fermentation
68375	27082	trehalose	+	fermentation
68375	16899	D-mannitol	+	fermentation
68375	16634	raffinose	-	fermentation
68375	17057	cellobiose	-	fermentation
68375	17632	nitrate	+	reduction
68375	17992	sucrose	+	fermentation
68375	59640	N-acetylglucosamine	+	fermentation
68375	32528	turanose	-	fermentation
68375	22599	arabinose	-	fermentation

metabolite production

@ref	Chebi-ID	metabolite	production
68375	15688	acetoin	yes
116632	35581	indole	no

metabolite tests

@ref	Chebi-ID	metabolite	voges-proskauer-test
68375	15688	acetoin	+
116632	15688	acetoin	+

enzymes

@ref	value	activity	ec
139	catalase	+	1.11.1.6
139	cytochrome-c oxidase	-	1.9.3.1
68375	beta-glucuronidase	-	3.2.1.31
68375	alkaline phosphatase	+	3.1.3.1
68375	L-arginine arylamidase	-
68375	beta-galactosidase	-	3.2.1.23
68375	beta-glucosidase	-	3.2.1.21
68375	ornithine decarboxylase	-	4.1.1.17
68375	arginine dihydrolase	+	3.5.3.6
68375	urease	+	3.5.1.5
116632	oxidase	-
116632	beta-galactosidase	+	3.2.1.23
116632	alcohol dehydrogenase	+	1.1.1.1
116632	gelatinase	-
116632	DNase	+
116632	catalase	+	1.11.1.6
116632	coagulase	+
116632	lecithinase	-
116632	lipase	-
116632	lysine decarboxylase	-	4.1.1.18
116632	ornithine decarboxylase	-	4.1.1.17
116632	protease	+
116632	urease	+	3.5.1.5
68382	alkaline phosphatase	+	3.1.3.1
68382	esterase (C 4)	+
68382	esterase lipase (C 8)	+
68382	lipase (C 14)	-
68382	leucine arylamidase	-	3.4.11.1
68382	valine arylamidase	-
68382	cystine arylamidase	+	3.4.11.3
68382	trypsin	-	3.4.21.4
68382	alpha-chymotrypsin	-	3.4.21.1
68382	acid phosphatase	+	3.1.3.2
68382	naphthol-AS-BI-phosphohydrolase	+
68382	alpha-galactosidase	-	3.2.1.22
68382	beta-galactosidase	-	3.2.1.23
68382	beta-glucuronidase	-	3.2.1.31
68382	alpha-glucosidase	+	3.2.1.20
68382	beta-glucosidase	-	3.2.1.21
68382	N-acetyl-beta-glucosaminidase	-	3.2.1.52
68382	alpha-mannosidase	-	3.2.1.24
68382	alpha-fucosidase	-	3.2.1.51

API zym

@ref	Control	Alkaline phosphatase	Esterase	Esterase Lipase	Lipase	Leucine arylamidase	Valine arylamidase	Cystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
116632	-	+	+	+	-	-	-	+	-	-	+	+	-	-	-	+	-	-	-	-

API ID32STA

@ref	URE	ADH Arg	ODC	ESC	GLU	FRU	MNE	MAL	LAC	TRE	MAN	RAF	RIB	CEL	NIT	VP	beta GAL	ArgA	PAL	PyrA	NOVO	SAC	NAG	TUR	ARA	beta GUR
139	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+/-	+	+	-	+/-	-	+	+	-	-	+	+	-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	-	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-

API biotype100

@ref	GLU	FRU	GAL	TRE	MNE	SBE	MEL	SAC	RAF	MTE	MAL	LAC	LTE	MbGa	MaGa	CEL	GEN	MbGu	ESC	RIB	ARA	XYL	PLE	RHA	FUC	MLZ	DARL	LARL	XLT	DUL	TAG	GLY	INO	MAN	MTL	TUR	SOR	ADO	HBG	LYX	ERY	MDG	3MDG	SAT	MUC	LTAT	DTAT	MTAT	DMLT	LMLT	CATE	TATE	TTE	CIT	GRT	GAT	2KG	5KG	TRY	NAG	GNT	PAC	PAT	pOBE	QAT	GTE	mOBE	BAT	PPAT	CMT	TGE	BET	PCE	ABT	HIN	LAT	CAP	CYT	HIS	SUC	FUM	GRE	GYT	AVT	ETN	TTN	GLN	ITA	3OBU	APT	GTT	PRO	DALA	LALA	SER	MNT	PROP	TYR	2KT
116632	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Isolation, sampling and environmental information

taxonmaps

@ref: 69479
File name: preview.99_3.png
url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_3;96_3;97_3;98_3;99_3&stattab=map
Last taxonomy: Staphylococcus
16S sequence: AB598746
Sequence Identity:
Total samples: 23199
soil counts: 353
aquatic counts: 991
animal counts: 21663
plant counts: 192

Safety information

risk assessment

@ref	pathogenicity human	pathogenicity animal	biosafety level	biosafety level comment
139	yes	yes	2	Risk group (German classification)
116632			2	Risk group (French classification)

Sequence information

16S sequences

@ref	description	accession	length	database	NCBI tax ID
67770	Staphylococcus aureus JCM 2151 gene for 16S rRNA, partial sequence	AB598746	1474	ena	1280
67770	Staphylococcus aureus NBRC 12732 gene for 16S rRNA, partial sequence	AB680336	1477	ena	1280

Genome sequences

@ref	description	accession	assembly level	database	NCBI tax ID
66792	Staphylococcus aureus NCTC7447	GCA_900457305	contig	ncbi	1280
66792	Staphylococcus aureus subsp. aureus JCM 2151	GCA_001312225	contig	ncbi	1295139
66792	Staphylococcus aureus strain NCTC7447	1280.18033	wgs	patric	1280
66792	Staphylococcus aureus subsp. aureus JCM 2151	1295139.3	wgs	patric	1295139
66792	Staphylococcus aureus aureus JCM 2151	2728369715	draft	img	1295139

Genome-based predictions

predictions

trait	prediction	confidence	training_data
spore-forming	no	99	no
motile	no	89.088	no
gram-positive	yes	88.247	no
anaerobic	no	99.434	no
aerobic	yes	87.725	no
halophile	yes	94.092	no
spore-forming	no	93.725	no
thermophile	no	99.655	no
glucose-util	yes	87.124	no
flagellated	no	90.975	no
glucose-ferment	yes	87.226	no

External links

@ref: 139

culture collection no.: CCUG 1828, CCM 2022, DSM 346, ATCC 6538P, CIP 53.156, NCTC 7447, WDCM 00033, JCM 2151, BCRC 10451, CECT 240, CGMCC 1.2910, FDA 209P, IAM 1011, IAM 12082, IFO 12732, IID 671, KCTC 1927, LMG 8195, NBRC 12732, NCFB 1963, NCIMB 8625, NRIC 1136, NRRL B-313, RIMD 3109007, IMET 10904, NCDO 1963, NRRL : B-313, IFO 3061, WDCM 00195

straininfo link

@ref: 83588
straininfo: 4992

literature

topic	Pubmed-ID	title	authors	journal	DOI	year	mesh	topic2
Pathogenicity	485130	New rapid assay for nafcillin in serum by spectrofluorometry.	Lichtenwalner DM, Suh B, Lorber B, Sugar AM	Antimicrob Agents Chemother	10.1128/AAC.16.2.210	1979	Biological Assay, Humans, Nafcillin/*blood, Spectrometry, Fluorescence/methods
Pathogenicity	578459	Biological properties and clinical application of propolis. III. Investigation of the sensitivity of Staphylococci isolated from pathological cases to ethanol extract of propolis (EEP). Attempts on inducing resistance in laboratory Staphylococcus strain to EEP.	Scheller S, Tustanowski J, Kurylo B, Paradowski Z, Obuszko Z	Arzneimittelforschung		1977	Anti-Bacterial Agents/pharmacology, Bees, Culture Media, Drug Resistance, Microbial, Humans, Resins, Plant/pharmacology, Staphylococcal Infections/microbiology, Staphylococcus/drug effects/isolation & purification, Time Factors	Cultivation
Pathogenicity	761993	Prevention of penicillin-induced lysis of Staphylococcus aureus by cellular lipoteichoic acid.	Suginaka H, Shimatani M, Ogawa M, Kotani S	J Antibiot (Tokyo)	10.7164/antibiotics.32.73	1979	Bacteriolysis/drug effects, Penicillin G/antagonists & inhibitors/pharmacology, Staphylococcus aureus/drug effects/growth & development, Teichoic Acids/*pharmacology, Time Factors
Metabolism	884150	Studies on bacterial cell wall inhibitors. III. 3-amino-3-deoxy-D-glucose, an inhibitor of bacterial cell wall synthesis.	Iwai Y, Tanaka H, Oiwa R, Shimizu S, Omura S	Biochim Biophys Acta	10.1016/0304-4165(77)90102-7	1977	Alanine/metabolism, Bacterial Proteins/biosynthesis, Cell Wall/drug effects/physiology, DNA, Bacterial/biosynthesis, Glucosamine/pharmacology, Kanamycin/pharmacology, Kinetics, Leucine/metabolism, Peptidoglycan/biosynthesis, RNA, Bacterial/biosynthesis, Species Specificity, Staphylococcus aureus/drug effects/*physiology, Thymidine/metabolism, Uridine/metabolism	Pathogenicity
Phylogeny	931810	Identification of producer and biological activities of new antibiotics, mimosamycin and chlorocarcins.	Mikami Y, Yokoyama K, Omi A, Arai T	J Antibiot (Tokyo)	10.7164/antibiotics.29.408	1976	Animals, Anti-Bacterial Agents/biosynthesis/pharmacology/therapeutic use, Antibiotics, Antineoplastic/isolation & purification/therapeutic use, Carcinoma, Ehrlich Tumor/drug therapy, Fungi/drug effects, Leukemia L1210/drug therapy, Mice, Streptomyces/classification/*metabolism	Enzymology
Metabolism	948143	Microorganism capable of decomposing N-acetylglucosaminyl ribitol teichoic acid of Staphylococcus aureus.	Iwata S, Tochikubo K, Kato K, Hirata T, Kotani S, Yagi K	Jpn J Microbiol	10.1111/j.1348-0421.1976.tb00918.x	1976	Bacillus/classification/enzymology, Bacteria/classification/enzymology/growth & development, Cell Wall/metabolism, Cell-Free System, Enzymes/metabolism, Hydrolysis, Soil Microbiology, Spores, Bacterial/growth & development, Staphylococcus aureus/metabolism, Teichoic Acids/*metabolism	Enzymology
	1083878	Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds.	Kohashi O, Pearson CM, Watanabe Y, Kotani S, Koga T	J Immunol		1976	Animals, Antigens, Bacterial, Arthritis, Rheumatoid/etiology/immunology, Cell Wall/immunology, Female, Lactobacillus/immunology, Mycobacterium/immunology, Peptidoglycan, Rats, Rats, Inbred Lew, Skin Tests, Staphylococcus aureus/immunology
	1116984	Characterization of the lipids of mesosomal vesicles and plasma membranes from Staphylococcus aureus.	Beining PR, Huff E, Prescott B, Theodore TS	J Bacteriol	10.1128/jb.121.1.137-143.1975	1975	Cardiolipins/analysis, Carotenoids/analysis, Cell Fractionation, Cell Membrane/analysis, Chromatography, DEAE-Cellulose, Chromatography, Thin Layer, Diglycerides/analysis, Fatty Alcohols/analysis, Glycosides/analysis, Lipids/analysis, Phospholipids/analysis, Protoplasts, Solvents, Staphylococcus/analysis/ultrastructure, Vitamin K/analysis
	1147743	Phagocytic properties of exudative microphages from animals with alloxan diabetes and insulin-induced hypoglycemia.	Danieluk-Gil I	Arch Immunol Ther Exp (Warsz)		1975	Alloxan/administration & dosage, Animals, Blood Glucose/analysis, Diabetes Mellitus, Experimental/immunology/pathology, Exudates and Transudates/cytology, Hypoglycemia/immunology/pathology, Injections, Subcutaneous, Insulin/administration & dosage, Liver/ultrastructure, Male, Mice, Pancreas/ultrastructure, Phagocytes/*immunology
Enzymology	1180873	Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum.	Kotani S, Watanabe Y, Shimono T, Kinoshita F, Narita T	Biken J		1975	Adjuvants, Immunologic, Animals, Antibody Formation, Cell Wall/analysis/immunology, Guinea Pigs, Hypersensitivity, Delayed, Lactobacillus/analysis/immunology, Ovalbumin/immunology, Peptidoglycan/analysis/immunology/isolation & purification, Staphylococcus aureus/analysis/*immunology	Phylogeny
Pathogenicity	1293906	[Evaluation of phagocytic activity of peripheral blood neutrophils in patients after kidney transplantation treated with cyclosporin and prednisone or with azathioprine with prednisone].	Hrycek A, Szoltysik I	Acta Haematol Pol		1992	Adolescent, Adult, Azathioprine/pharmacology, Cyclosporine/pharmacology, Female, Humans, Kidney Transplantation/immunology, Male, Middle Aged, Neutrophils/drug effects, Phagocytosis/*drug effects, Prednisone/pharmacology, Staphylococcus aureus/drug effects
Cultivation	1297243	[The effect of culture media on bacteriocin production in various strains of bacteria].	Laukova A	Vet Med (Praha)		1992	Bacteriocins/biosynthesis, Culture Media, Enterococcus/metabolism, Staphylococcus/metabolism	Metabolism
Phylogeny	1367491	Expression of penicillin G acylase gene from Bacillus megaterium ATCC 14945 in Escherichia coli and Bacillus subtilis.	Kang JH, Hwang Y, Yoo OJ	J Biotechnol	10.1016/0168-1656(91)90001-c	1991	Bacillus megaterium/enzymology/genetics, Bacillus subtilis/genetics, Bacterial Proteins/biosynthesis/genetics, Cephalosporins/metabolism, Escherichia coli/genetics, Gene Expression Regulation, Enzymologic, Genetic Vectors, Molecular Weight, Penicillin Amidase/biosynthesis/genetics, Recombinant Fusion Proteins/biosynthesis, Species Specificity, Substrate Specificity	Enzymology
Enzymology	1699048	[Determination of the enterotoxigenicity of conditionally pathogenic microorganisms using the method of suppressing the dehydrogenase activity of the UV mutant Staphylococcus aureus 209 P].	Kalinina TE, Ternovskaia LN, Andrusenko IT, Kaminskaia VP, Ved'mina EA, Shepelev AP	Lab Delo		1990	Bacteriological Techniques, Enterobacteriaceae/pathogenicity, Enterotoxins/analysis	Pathogenicity
Pathogenicity	1715631	[The action of tomicide on macromolecular synthesis in bacterial cells].	Butova LG, Blinkova LP	Zh Mikrobiol Epidemiol Immunobiol		1991	Anti-Bacterial Agents/pharmacology, Anti-Infective Agents, Local/pharmacology, Bacteriocins, DNA, Bacterial/biosynthesis/drug effects, Depression, Chemical, Dose-Response Relationship, Drug, Leucine/drug effects/metabolism, Macromolecular Substances, RNA, Bacterial/biosynthesis/drug effects, Staphylococcus aureus/*drug effects/metabolism, Thymidine/metabolism, Time Factors, Tritium, Uridine/metabolism	Metabolism
Pathogenicity	1791781	[The effect of the antibiotic AL-87 on the amino acid yield from Staphylococcus aureus 209P cells].	Snirnov VV, Churkina LN, Kiprianova EA, Pustovalova LI	Mikrobiol Zh		1991	Amino Acids/analysis/drug effects, Anti-Bacterial Agents/pharmacology, Culture Media/analysis, Dose-Response Relationship, Drug, Pseudomonas, Staphylococcus aureus/chemistry/*drug effects	Biotechnology
Pathogenicity	1884976	Suppression of penicillin-induced lysis of Staphylococcus aureus by cibacron blue 3G-A.	Sugai M, Ooku K, Akiyama T, Inoue S, Iseda S, Miyake Y, Suginaka H	FEMS Microbiol Lett	10.1016/0378-1097(91)90586-y	1991	Bacteriolysis/drug effects, Coloring Agents/pharmacology, Penicillin G/pharmacology, Staphylococcus aureus/drug effects, Triazines/*pharmacology
Pathogenicity	2013242	Effects of antibiotics on nonopsonized adherence of Staphylococcus aureus to human polymorphonuclear leukocytes.	Kohada A, Miyake Y, Sugai M, Tsuru H, Suginaka H	Chemotherapy	10.1159/000238832	1991	Aminoglycosides, Anti-Bacterial Agents/pharmacology, Bacterial Adhesion/drug effects, Humans, Lactams, Neutrophils/drug effects/physiology, Phagocytosis, Staphylococcus aureus/drug effects/physiology
Enzymology	2085620	[Hydrolysis of a Staphylococcus aureus cell wall peptidoglycan by 209 P lysoamidase].	Severin AI, Il'chenko VIa, Kulaev IS	Biokhimiia		1990	Amino Acid Sequence, Carbohydrate Sequence, Cell Wall/enzymology, Chromatography, Liquid, Electrophoresis, Paper, Hydrolysis, Molecular Sequence Data, Peptide Hydrolases/chemistry, Peptidoglycan/metabolism, Staphylococcus aureus/*enzymology	Genetics
Pathogenicity	2389120	The effect of zinc oxide on Staphylococcus aureus and polymorphonuclear cells in a tissue cage model.	Sunzel B, Lasek J, Soderberg T, Elmros T, Hallmans G, Holm S	Scand J Plast Reconstr Surg Hand Surg	10.3109/02844319009004517	1990	Animals, Chemotaxis/drug effects, Diffusion Chambers, Culture, Guinea Pigs, Models, Biological, Neutrophils/drug effects, Rabbits, Staphylococcus aureus/drug effects, Zinc/pharmacology, Zinc Oxide/*pharmacology
Pathogenicity	2447280	Effects of mucopolysaccharides on penicillin-induced lysis of Staphylococcus aureus.	Kiriyama T, Miyake Y, Sugai M, Kobayashi K, Yoshiga K, Takada K, Suginaka H	J Med Microbiol	10.1099/00222615-24-4-325	1987	Bacteriolysis/drug effects, Chondroitin Sulfates/pharmacology, Dextran Sulfate, Dextrans/pharmacology, Drug Interactions, Glycosaminoglycans/pharmacology, Heparin/pharmacology, Hyaluronic Acid/pharmacology, Lipopolysaccharides/metabolism, Mitogens/pharmacology, Penicillin G/pharmacology, Staphylococcus aureus/drug effects, Teichoic Acids/metabolism	Metabolism
Pathogenicity	2481139	[A stat-method of determining antibiotic concentration in biological fluids].	Pasternak NA, Shenderovich VA, Ved'mina EA	Lab Delo		1989	Anti-Bacterial Agents/analysis, Body Fluids/analysis, Humans, Immunodiffusion, Oxidoreductases/antagonists & inhibitors, Staphylococcus aureus/enzymology	Enzymology
Pathogenicity	2509599	[Production of oxygen free radicals by phagocytes in patients on hemodialysis].	Ueda Y	Kansenshogaku Zasshi	10.11150/kansenshogakuzasshi1970.63.997	1989	Adult, Aged, Anti-Bacterial Agents/pharmacology, Female, Free Radicals, Humans, Klebsiella pneumoniae/drug effects, Luminescent Measurements, Male, Middle Aged, Oxygen/metabolism, Phagocytes/metabolism, *Renal Dialysis	Metabolism
Enzymology	2515095	Purification of a 51 kDa endo-beta-N-acetylglucosaminidase from Staphylococcus aureus.	Sugai M, Koike H, Hong YM, Miyake Y, Nogami R, Suginaka H	FEMS Microbiol Lett	10.1016/0378-1097(89)90209-7	1989	Acetylglucosaminidase/isolation & purification, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel, Hexosaminidases/isolation & purification, Isoelectric Point, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Molecular Weight, Staphylococcus aureus/*enzymology	Phylogeny
Pathogenicity	2694953	Comparison of electronic and viability counting methods for determination of postantibiotic effect of oxacillin on Staphylococcus aureus.	Nadler HL, Curby WA, Forgacs P, Rosenberg F	Antimicrob Agents Chemother	10.1128/AAC.33.12.2155	1989	Bacteriological Techniques, Microbial Sensitivity Tests, Oxacillin/pharmacology, Staphylococcus aureus/drug effects
Pathogenicity	2775357	Aminoglycosides enhance the adherence of Staphylococcus aureus to HeLa cells.	Miyake Y, Kohada A, Fujii I, Sugai M, Suginaka H	J Antimicrob Chemother	10.1093/jac/23.1.79	1989	Aminoglycosides, Anti-Bacterial Agents/pharmacology, Bacterial Adhesion/drug effects, HeLa Cells, Humans, Staphylococcus aureus/*physiology
Enzymology	2847648	DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity.	Takahata M, Nishino T	Antimicrob Agents Chemother	10.1128/AAC.32.8.1192	1988	4-Quinolones, Anti-Infective Agents/pharmacology, DNA Topoisomerases, Type II/analysis/isolation & purification, DNA, Bacterial/analysis, DNA, Superhelical/analysis, Electrophoresis, Agar Gel, Staphylococcus aureus/drug effects/enzymology, *Topoisomerase II Inhibitors	Phylogeny
Pathogenicity	3144613	[Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].	Saionji K	Jpn J Antibiot		1988	Albumins/pharmacology, Cephalosporins/pharmacology, Escherichia coli/drug effects, Humans, Microbial Sensitivity Tests, Monobactams/pharmacology, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	3701783	Synthesis of delta 3-1-methylene-1-carbacephems.	Herdewijn P, Claes PJ, Vanderhaeghe H	J Med Chem	10.1021/jm00155a013	1986	Cephalexin/pharmacology, Cephalosporins/*chemical synthesis/pharmacology, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Staphylococcus aureus/drug effects
Pathogenicity	4084017	Phagocytic and bactericidal activities of neutrophils in duodenal ulcer patients during cimetidine treatment.	Markiewicz K, Kowalska M, Malec P, Denys A	Arch Immunol Ther Exp (Warsz)		1985	Adult, Aged, Cimetidine/therapeutic use, Duodenal Ulcer/blood/drug therapy, Female, Humans, Kinetics, Male, Middle Aged, Neutrophils/drug effects/immunology/physiology, Phagocytosis/drug effects, Staphylococcus aureus/immunology	Enzymology
Enzymology	4106221	Electron microscopy during release and purification of mesosomal vesicles and protoplast membranes from Staphylococcus aureus.	Popkin TJ, Theodore TS, Cole RM	J Bacteriol	10.1128/jb.107.3.907-917.1971	1971	Acetates, Cell Membrane, Centrifugation, Density Gradient, Cesium, Chlorides, Deoxyribonucleases, Enzymes, Lead, Microscopy, Electron, Organoids, Osmosis, Phosphotungstic Acid, Protoplasts/cytology, Ribonucleases, Staining and Labeling, Staphylococcus/cytology/growth & development, Sucrose, Uranium
Pathogenicity	4166078	Antibiotic sensitivity of Micrococcus radiodurans.	Hawiger J, Jeljaszewicz J	Appl Microbiol	10.1128/am.15.2.304-306.1967	1967	Anti-Bacterial Agents/pharmacology, Bacitracin/pharmacology, Chloramphenicol/pharmacology, Dactinomycin/pharmacology, Dihydrostreptomycin Sulfate/pharmacology, Erythromycin/pharmacology, Kanamycin/pharmacology, Micrococcus/drug effects, Mitomycins/pharmacology, Neomycin/pharmacology, Penicillin G/pharmacology, *Penicillin Resistance, Vancomycin/pharmacology
Enzymology	4373433	Cellular location of degradative enzymes in Staphylococcus aureus.	Nugent KM, Huff E, Cole RM, Theodore TS	J Bacteriol	10.1128/jb.120.3.1012-1016.1974	1974	Acid Phosphatase/metabolism, Adenosine Triphosphatases/metabolism, Alkaline Phosphatase/metabolism, Aminohydrolases/metabolism, Cell Fractionation, Cell Membrane/enzymology, Cytoplasm/enzymology, Endonucleases/metabolism, Enzyme Induction, Glucosephosphate Dehydrogenase/metabolism, Hexokinase/metabolism, Microscopy, Electron, Nucleotidases/metabolism, Penicillinase/biosynthesis, Peptide Hydrolases/isolation & purification/metabolism, Phosphoric Monoester Hydrolases/isolation & purification, Protoplasts/enzymology, Staphylococcus/*enzymology/ultrastructure, Subcellular Fractions/enzymology	Metabolism
Enzymology	4424507	Lipoteichoic acid localization in mesosomal vesicles of Staphylococcus aureus.	Huff E, Cole RM, Theodore TS	J Bacteriol	10.1128/jb.120.1.273-281.1974	1974	Cell Fractionation, Cell Membrane/analysis, Chromatography, Gas, Chromatography, Paper, Fatty Acids/analysis, Glycerol/analysis, Glycerophosphates/analysis, Hydrolysis, Lipids/analysis, Organoids/analysis, Phosphates/analysis, Protoplasts, Solvents, Staphylococcus/analysis, Teichoic Acids/analysis/*isolation & purification	Phylogeny
Pathogenicity	4670428	Four-hour microbiological assay of gentamicin in serum.	Warren E, Snyder RJ, Washington JA II	Antimicrob Agents Chemother	10.1128/AAC.1.1.46	1972	Biological Assay, Gentamicins/blood/pharmacology, Staphylococcus/drug effects, Time Factors
Enzymology	4745430	Protein and fatty acid composition of mesosomal vesicles and plasma membranes of Staphylococcus aureus.	Theodore TS, Panos C	J Bacteriol	10.1128/jb.116.2.571-576.1973	1973	Bacterial Proteins/analysis/isolation & purification, Cell Membrane/analysis, Chromatography, Gas, Densitometry, Electrophoresis, Polyacrylamide Gel, Fatty Acids/analysis, Sodium Dodecyl Sulfate, Staphylococcus/cytology	Phylogeny
Pathogenicity	5423366	Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.	Huber TW, Schuhardt VT	J Bacteriol	10.1128/jb.103.1.116-119.1970	1970	Agar, Anti-Bacterial Agents/pharmacology, Cell Wall/analysis/drug effects, Culture Media, Hexosamines/analysis, L Forms/drug effects, Lysostaphin/pharmacology, Manometry, Osmotic Fragility, Oxygen Consumption, Polysaccharides, Bacterial/analysis, Protoplasts/metabolism, Serotyping, Sodium Chloride, Staphylococcus/analysis/*drug effects/growth & development, Time Factors	Cultivation
Pathogenicity	5647523	Differential chromatographic bioassay for the gentamicin complex.	Wagman GH, Oden EM, Weinstein MJ	Appl Microbiol	10.1128/am.16.4.624-627.1968	1968	Biological Assay, Chromatography, Paper, Gentamicins/analysis/pharmacology, Methods, Staphylococcus/drug effects
Pathogenicity	5732506	Osmotic fragility and viability of lysostaphin-induced staphylococcal spheroplasts.	Schuhardt VT, Klesius PH	J Bacteriol	10.1128/jb.96.3.734-737.1968	1968	Anti-Bacterial Agents/pharmacology, Hypertonic Solutions, Lysostaphin/pharmacology, Osmosis, Protoplasts, Sodium Chloride/pharmacology, Staphylococcus/*drug effects/growth & development, Sucrose/pharmacology
Pathogenicity	5764340	Electron microscopy and viability of lysostaphin-induced staphylococcal spheroplasts, protoplast-like bodies, and protoplasts.	Schuhardt VT, Huber TW, Pope LM	J Bacteriol	10.1128/jb.97.1.396-401.1969	1969	Anti-Bacterial Agents/pharmacology, Cell Wall/drug effects, DNA, Bacterial, Lysostaphin/pharmacology, Microscopy, Electron, Osmotic Fragility, Peptides, *Protoplasts, Spectrophotometry, Tritium
	6077408	Enhancement of antibiotic activity against Staphylococcus aureus by exposure to hyperbaric oxygen.	Bornside GH	Appl Microbiol	10.1128/am.15.5.1020-1024.1967	1967	Anti-Bacterial Agents/pharmacology, Cephalothin/pharmacology, Kanamycin/pharmacology, Oxygen/pharmacology, Oxytetracycline/pharmacology, Penicillins/pharmacology, Pressure, Staphylococcus/*growth & development, Streptomycin/pharmacology, Tetracycline/pharmacology
Enzymology	6301566	Synthesis of N-(2-hydroxypropyl)methacrylamide copolymers with antimicrobial activity.	Solovskij MV, Ulbrich K, Kopecek J	Biomaterials	10.1016/0142-9612(83)90069-8	1983	Acrylates/chemical synthesis, Ampicillin, Anti-Bacterial Agents/chemical synthesis/pharmacology, Bacteria/drug effects, Kinetics, Methacrylates/*chemical synthesis/pharmacology, Penicillanic Acid	Pathogenicity
Pathogenicity	6353817	[Model UF-2 mutant of Staphylococcus aureus 209 P for titrating Vibrio cholera enterotoxin].	Pasternak NA, Ved'mina EA, Andrusenko IT, Shenderovich VA, Zhuravleva TP	Zh Mikrobiol Epidemiol Immunobiol		1983	Animals, Animals, Suckling, Bacteriological Techniques, Carcinoma, Ehrlich Tumor/microbiology, Enterotoxins/analysis/pharmacology/toxicity, Guinea Pigs, In Vitro Techniques, Intestines/drug effects, Mutation, Oxidoreductases/metabolism, Rabbits, Skin Absorption/drug effects, Staphylococcus aureus/*drug effects/enzymology, Vibrio cholerae/pathogenicity	Enzymology
Pathogenicity	6364128	[Antifungal and antimicrobial activity of beta-ionone and vitamin A derivatives].	Mikhlin ED, Radina VP, Dmitrovskii AA, Blinkova LP, Butova LG	Prikl Biokhim Mikrobiol		1983	Anti-Bacterial Agents, Anti-Infective Agents/pharmacology, Antifungal Agents/pharmacology, Fusarium/drug effects, Microbial Sensitivity Tests, Micrococcus/drug effects, Mitosporic Fungi/drug effects, Norisoprenoids, Retinoids/pharmacology, Spores, Fungal/drug effects, Staphylococcus aureus/drug effects, Streptococcus pyogenes/drug effects, Structure-Activity Relationship, Terpenes/*pharmacology
Enzymology	6647420	[Action of dioxidine on the membrane apparatus of the bacterial cell].	Rudzit EA, Ermachenko VA, Kutsemako RT, Dzhemukhadze GK, Kharat'ian EF	Prikl Biokhim Mikrobiol		1983	Anti-Bacterial Agents/pharmacology, Cell Membrane/drug effects/enzymology, Cytochromes/metabolism, Micrococcus/drug effects/enzymology, Oxidoreductases/metabolism, Protoplasts/drug effects/enzymology, Quinoxalines/pharmacology, Staphylococcus aureus/drug effects/enzymology	Pathogenicity
Pathogenicity	6732206	[Fatty acid composition of variant Staphylococcus aureus 209 P resistant to antibiotic AL-87].	Smirnov VV, Churkina LN, Vasiurenko ZP, Kiprianova EA, Garagulia AD	Antibiotiki		1984	Anti-Bacterial Agents/antagonists & inhibitors, Chromatography, Gas, Drug Resistance, Microbial, Fatty Acids/analysis, Genetic Variation/drug effects, Pseudomonas, Staphylococcus aureus/analysis/cytology/drug effects
Enzymology	6832811	Production, purification, and properties of a bacteriocin from Staphylococcus aureus isolated from saliva.	Nakamura T, Yamazaki N, Taniguchi H, Fujimura S	Infect Immun	10.1128/iai.39.2.609-614.1983	1983	Amino Acids/analysis, Bacteria/growth & development, Bacteriocins/analysis/biosynthesis/isolation & purification/pharmacology, Humans, Isoelectric Point, Molecular Weight, Saliva/microbiology, Staphylococcus aureus/isolation & purification/*metabolism	Phylogeny
	6967453	Influence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid.	Beining PR, Flannery GM, Prescott B, Baker PJ	Infect Immun	10.1128/iai.29.1.132-139.1980	1980	Animals, Antibodies, Bacterial/biosynthesis, Antibody Specificity, Antibody-Producing Cells/immunology, Female, Immunization, Immunoglobulin M/biosynthesis, Lipopolysaccharides, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Phosphatidic Acids/immunology, Staphylococcus aureus/immunology, T-Lymphocytes/immunology, Teichoic Acids/immunology
	7447634	Effect of immunization of guinea pigs on in vitro phagocytosis by polymorphonuclear leukocytes (PMNL).	Tchorzewski H, Denys A, Grzybowski A, Malewska Z	Arch Immunol Ther Exp (Warsz)		1980	Animals, Antigens/immunology, Antigens, Viral/immunology, Cattle, Guinea Pigs, In Vitro Techniques, Influenza A virus/immunology, Neutrophils/immunology, Orthomyxoviridae/immunology, Phagocytosis, Serum Albumin, Bovine/immunology, Staphylococcus aureus/immunology
Enzymology	7494504	Alteration of bacteriolytic enzyme profile of Staphylococcus aureus during growth.	Komatsuzawa H, Sugai M, Nakashima S, Suginaka H	Microbiol Immunol	10.1111/j.1348-0421.1995.tb02253.x	1995	N-Acetylmuramoyl-L-alanine Amidase/isolation & purification/metabolism, Staphylococcus aureus/enzymology/growth & development	Phylogeny
Metabolism	7628982	Binding affinities of beta-lactam antibodies for penicillin-binding protein 2' in methicillin-resistant staphylococcus aureus.	Sumita Y, Fukasawa M, Mitsuhashi S, Inoue M	J Antimicrob Chemother	10.1093/jac/35.4.473	1995	Anti-Bacterial Agents/immunology, Antibodies, Bacterial/metabolism, Bacterial Proteins, Carrier Proteins/genetics/metabolism, Hexosyltransferases, Kinetics, Membranes/metabolism, Methicillin Resistance/genetics, Microbial Sensitivity Tests, Muramoylpentapeptide Carboxypeptidase/genetics/metabolism, Penicillin-Binding Proteins, Peptidyl Transferases, Protein Binding, Staphylococcus aureus/drug effects/genetics/*metabolism, beta-Lactams	Enzymology
Phylogeny	7723694	Isolation and characterization of Staphylococcus aureus mutants which form altered cell clusters.	Sugai M, Komatsuzawa H, Ooku-Inomata K, Miyake Y, Ishida E, Suginaka H	Microbiol Immunol	10.1111/j.1348-0421.1994.tb02158.x	1994	Acetylglucosaminidase/analysis, Muramidase/analysis, N-Acetylmuramoyl-L-alanine Amidase/genetics, Staphylococcus aureus/cytology/enzymology/*genetics	Enzymology
Enzymology	7883705	Identification of endo-beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus.	Sugai M, Komatsuzawa H, Akiyama T, Hong YM, Oshida T, Miyake Y, Yamaguchi T, Suginaka H	J Bacteriol	10.1128/jb.177.6.1491-1496.1995	1995	Acetylglucosaminidase/isolation & purification/metabolism/pharmacology, Bacterial Adhesion/physiology, Bacterial Proteins/isolation & purification/metabolism/pharmacology, Bacteriolysis, Blotting, Western, Mutagenesis, Insertional, Particle Size, Staphylococcus aureus/enzymology/growth & development	Phylogeny
Pathogenicity	7898564	Bacteriological evaluation of a new air turbine handpiece for preventing cross-contamination in dental procedures.	Masuda K, Ohta M, Ohsuka S, Matsuyama M, Ashoori M, Usami T, Ito M, Ueda M, Kaneda T	Nagoya J Med Sci		1994	Bacteriological Techniques, Cross Infection/prevention & control/transmission, Decontamination, Dental Equipment, Evaluation Studies as Topic, Humans, *Infectious Disease Transmission, Patient-to-Professional
Metabolism	8067117	[The interaction of staphylococci with plasmin and its inhibitors].	Zorin NA, Zhabin SG, Vorob'eva ON	Zh Mikrobiol Epidemiol Immunobiol		1993	Animals, Bacterial Proteins/metabolism, Cell Wall/metabolism, Drug Interactions, Fibrinolysin/antagonists & inhibitors/metabolism, Humans, Interferon-alpha/metabolism, Molecular Weight, Rabbits, Receptors, Cell Surface/metabolism, Receptors, Interferon/metabolism, Receptors, Peptide/metabolism, Receptors, Urokinase Plasminogen Activator, Staphylococcus aureus/*metabolism	Pathogenicity
Cultivation	8319007	[Modeling of the bactericidal effect of spiramycin. Choice of a pharmacodynamic model].	Renard L, Sanders P, Laurentie M	Vet Res		1993	Culture Media, Dose-Response Relationship, Drug, Hydrogen-Ion Concentration, Models, Biological, Spiramycin/pharmacology, Staphylococcus aureus/*drug effects/growth & development, Time Factors	Pathogenicity
Pathogenicity	8572896	Effect of hydrocortisone treatment on oxygen metabolism and phagocytosis of peripheral blood neutrophils in asthmatic patients, sensitive and resistant to glucocorticosteroid therapy.	Jankowska R, Zak-Nejmark T, Malolepszy J, Nadobna G, Osos M, Medrala W	Arch Immunol Ther Exp (Warsz)		1994	Adult, Asthma/blood/drug therapy, Drug Resistance, Humans, Hydrocortisone/therapeutic use, Luminescent Measurements, Middle Aged, Neutrophils/drug effects/metabolism, Oxygen/blood, Phagocytosis/*drug effects	Metabolism
Pathogenicity	8879559	Synthesis and biological evaluation of an electronically activated isooxacephem.	Hakimelahi GH, Tsay SC, Tso HH, Ramezani Z, Hwu JR	Bioorg Med Chem	10.1016/0968-0896(96)00131-9	1996	Anti-Bacterial Agents/chemistry, Cephalosporins/chemistry, Microbial Sensitivity Tests, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	9032632	Prevention of infection in dental procedures.	Matsuyama M, Usami T, Masuda K, Niimi N, Ohta M, Ueda M	J Hosp Infect	10.1016/s0195-6701(97)90164-x	1997	Adult, Colony Count, Microbial, Cross Infection/prevention & control, Dental High-Speed Equipment, Disinfection/methods, Equipment Contamination/prevention & control, Equipment Design, Humans, Infection Control, Dental/*methods, Staphylococcus aureus, Streptococcus mutans, Suction
Phylogeny	9142742	Isolation and characterization of autolysin-defective mutants of Staphylococcus aureus that form cell packets.	Kaneda S	Curr Microbiol	10.1007/s002849900195	1997	Methylnitronitrosoguanidine, Mutagenesis, Mutation, N-Acetylmuramoyl-L-alanine Amidase/genetics, Staphylococcus aureus/cytology/*genetics/growth & development
Enzymology	9299402	Identification of nitric oxide synthase in Staphylococcus aureus.	Choi WS, Chang MS, Han JW, Hong SY, Lee HW	Biochem Biophys Res Commun	10.1006/bbrc.1997.7189	1997	Blotting, Western, Chromatography, High Pressure Liquid, Chromatography, Thin Layer, Citrulline/metabolism, Electrophoresis, Polyacrylamide Gel, Kinetics, NADP/metabolism, Nitric Oxide/analysis, Nitric Oxide Synthase/isolation & purification/metabolism, Staphylococcus aureus/enzymology, Thermodynamics	Metabolism
Pathogenicity	9341918	Cephalosporin 3'-phloroglucide esters and 7-(phloroglucidamido) cephalosporins as novel antibacterial agents.	Hwu JR, Moshfegh AA, Tsay SC, Lin CC, Tseng WN, Azaripour A, Mottaghian H, Hakimelahi GH	J Med Chem	10.1021/jm960810e	1997	Anti-Bacterial Agents, Anti-Infective Agents/chemical synthesis/chemistry/pharmacology, Benzhydryl Compounds/chemical synthesis/pharmacology, Benzophenones/chemical synthesis/pharmacology, Candida albicans/drug effects, Cephalosporins/chemical synthesis/chemistry/pharmacology, Esters/chemical synthesis/pharmacology, Microbial Sensitivity Tests, Models, Molecular, Molecular Conformation, Molecular Structure, Pseudomonas aeruginosa/drug effects, Staphylococcus aureus/drug effects, beta-Lactamase Inhibitors
Pathogenicity	9394239	[Evaluation of reduced vancomycin susceptibility of MRSA strain Mu50 with various conditions of antibiotic susceptibility tests].	Hanaki H, Hiramatsu K	Jpn J Antibiot		1997	Anti-Bacterial Agents/pharmacology, Drug Resistance, Microbial, Humans, Methicillin Resistance, Microbial Sensitivity Tests/methods, Staphylococcal Infections/microbiology, Staphylococcus aureus/drug effects/isolation & purification, Surgical Wound Infection/microbiology, Vancomycin/*pharmacology	Enzymology
Pathogenicity	9400512	Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.	Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I	Lancet	10.1016/S0140-6736(97)07324-8	1997	Aged, Aged, 80 and over, Anti-Bacterial Agents/pharmacology, Drug Resistance, Microbial, Electrophoresis, Gel, Pulsed-Field, Genotype, Hospitals, Humans, Japan, Male, Methicillin Resistance, Microbial Sensitivity Tests, Prevalence, Sputum/microbiology, Staphylococcus aureus/drug effects/genetics, Vancomycin/pharmacology	Enzymology
Metabolism	9597552	[Mechanism of vancomycin resistance in MRSA strain Mu50].	Hanaki H, Labischinski H, Sasaki K, Kuwahara-Arai K, Inaba Y, Hiramatsu K	Jpn J Antibiot		1998	Anti-Bacterial Agents/metabolism/pharmacology, Bacterial Proteins, Binding Sites, Carrier Proteins/metabolism, Cell Wall/metabolism/ultrastructure, Drug Resistance, Microbial, Hexosyltransferases, Humans, Methicillin Resistance, Microscopy, Electron, Scanning Transmission, Muramoylpentapeptide Carboxypeptidase/metabolism, Penicillin-Binding Proteins, Peptidoglycan/metabolism, Peptidyl Transferases, Pneumonia, Staphylococcal/microbiology, Staphylococcus aureus/cytology/drug effects/metabolism, Surgical Wound Infection/microbiology, Vancomycin/metabolism/pharmacology	Pathogenicity
Metabolism	9644600	[Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50].	Hanaki H, Labischinski H, Inaba Y, Hiramatsu K	Jpn J Antibiot		1998	Acetylglucosamine/metabolism, Anti-Bacterial Agents/pharmacokinetics/pharmacology, Cell Wall/metabolism, Dose-Response Relationship, Drug, Drug Resistance, Microbial, Humans, Peptidoglycan/metabolism, Staphylococcus aureus/drug effects/metabolism, Vancomycin/pharmacokinetics/*pharmacology	Pathogenicity
Pathogenicity	9796192	[In vitro specific binding of Shiga toxin 1 and 2 by TAK-751S (Gb3 analog)].	Takeda T, Yoshino K, Adachi E, Yamagata K, Uchida H, Okonogi K, Iizawa Y	Kansenshogaku Zasshi	10.11150/kansenshogakuzasshi1970.72.924	1998	Adsorption, Bacterial Toxins, Diatomaceous Earth, Enterotoxins, Escherichia coli O157, Humans, Shiga Toxins, Trihexosylceramides, Trisaccharides
	10028666	Identification and semiquantitative estimation of antibiotics added to complete feeds, premixes, and concentrates.	Gafner JL	J AOAC Int		1999	Animal Feed, Anti-Bacterial Agents/analysis, Chromatography, Thin Layer, Glycopeptides, Microbial Sensitivity Tests, *Quality Control, Software Design
Pathogenicity	10349564	Feasibility of an in vitro microbiological model as an alternative to the rabbit eye model.	Devarajan PV, Bhogte CP, Majali AB, Sabharwal S	Drug Dev Ind Pharm	10.1081/ddc-100102238	1999	Administration, Topical, Animal Testing Alternatives/methods, Animals, Evaluation Studies as Topic, Eye/microbiology, Gentamicins/administration & dosage, In Vitro Techniques, Male, Models, Biological, Polyvinyl Alcohol/chemistry, Pseudomonas aeruginosa/drug effects, Rabbits, Staphylococcus aureus/*drug effects, Time Factors
Cultivation	10419208	Modeling the aerobic growth and decline of Staphylococcus aureus as affected by pH and potassium sorbate concentration.	Giannuzzi L, Contreras E, Zaritzky N	J Food Prot	10.4315/0362-028x-62.4.356	1999	Aerobiosis, Colony Count, Microbial, Culture Media, Hydrogen-Ion Concentration, Models, Biological, Sorbic Acid/pharmacology, Staphylococcus aureus/drug effects/*growth & development	Pathogenicity
Pathogenicity	10991847	In vitro antimicrobial properties of recombinant ASABF, an antimicrobial peptide isolated from the nematode Ascaris suum.	Zhang H, Yoshida S, Aizawa T, Murakami R, Suzuki M, Koganezawa N, Matsuura A, Miyazawa M, Kawano K, Nitta K, Kato Y	Antimicrob Agents Chemother	10.1128/AAC.44.10.2701-2705.2000	2000	Amino Acid Sequence, Animals, Anti-Bacterial Agents/antagonists & inhibitors/biosynthesis/pharmacology, Ascaris suum/chemistry/metabolism, Bacteria/drug effects, Chromatography, High Pressure Liquid, Chromatography, Ion Exchange, Genetic Vectors, Helminth Proteins/antagonists & inhibitors/biosynthesis/pharmacology, Hemolysis/drug effects, Humans, In Vitro Techniques, Microbial Sensitivity Tests, Molecular Sequence Data, Recombinant Proteins/pharmacology, Yeasts/drug effects	Genetics
Pathogenicity	11020277	Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.	Hakimelahi GH, Moosavi-Movahedi AA, Tsay SC, Tsai FY, Wright JD, Dudev T, Hakimelahi S, Lim C	J Med Chem	10.1021/jm000213z	2000	Carbapenems/chemical synthesis/chemistry/pharmacology, Colony Count, Microbial, Drug Resistance, Microbial, Enzyme Inhibitors/chemical synthesis/chemistry/pharmacology, Microbial Sensitivity Tests, Models, Molecular, Stenotrophomonas maltophilia/chemistry/drug effects, Stereoisomerism, Structure-Activity Relationship, beta-Lactamases/chemistry
Pathogenicity	11293238	Antimicrobial activity of selected non-antibiotics--activity of methotrexate against Staphylococcus aureus strains.	Kruszewska H, Zareba T, Tyski S	Acta Pol Pharm		2000	Anti-Bacterial Agents/pharmacology, Humans, Methicillin Resistance, Methotrexate/pharmacology, Staphylococcus aureus/*drug effects
Enzymology	11397624	Effects of Helichrysum italicum extract on growth and enzymatic activity of Staphylococcus aureus.	Nostro A, Bisignano G, Angela Cannatelli M, Crisafi G, Paola Germano M, Alonzo V	Int J Antimicrob Agents	10.1016/s0924-8579(01)00336-3	2001	Anti-Bacterial Agents/isolation & purification/pharmacology, Asteraceae, Coagulase/antagonists & inhibitors, Deoxyribonucleases/antagonists & inhibitors, Enzyme Inhibitors/isolation & purification/pharmacology, Humans, In Vitro Techniques, Lipase/antagonists & inhibitors, Micrococcal Nuclease/antagonists & inhibitors, Plant Extracts/pharmacology, Plants, Medicinal, Staphylococcus aureus/*drug effects/enzymology/growth & development/isolation & purification	Phylogeny
Phylogeny	11509983	Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids.	Scazzocchio F, Cometa MF, Tomassini L, Palmery M	Planta Med	10.1055/s-2001-16493	2001	Alkaloids/chemistry/isolation & purification/pharmacology, Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Bacteria/drug effects, Magnoliopsida/chemistry, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Time Factors	Enzymology
Pathogenicity	11548201	Comparison of the effects in vitro of tea tree oil and plaunotol on methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus.	Hada T, Furuse S, Matsumoto Y, Hamashima H, Masuda K, Shiojima K, Arai T, Sasatsu M	Microbios		2001	Anti-Bacterial Agents/pharmacology, Diterpenes, Fatty Alcohols/pharmacology, Humans, Methicillin/pharmacology, Methicillin Resistance, Microbial Sensitivity Tests/methods, Oils, Volatile/pharmacology, Penicillins/pharmacology, Staphylococcus aureus/drug effects/growth & development, Tea Tree Oil/*pharmacology
Pathogenicity	12024816	[The effect of the intra- and extracellular metabolites of microorganisms isolated from various ecotopes on the catalase activity of Staphylococcus aureus 6538P].	Bukharin OV, Sgibnev AV, Cherkasov SV, Ivanov IuB	Mikrobiologiia		2002	Biological Factors/pharmacology, Catalase/antagonists & inhibitors, Culture Media, Enzyme Inhibitors/pharmacology, Humans, Hydrogen Peroxide/pharmacology, Staphylococcus aureus/drug effects/*enzymology/growth & development	Cultivation
Pathogenicity	12475283	Green-leaf-derived C6-aroma compounds with potent antibacterial action that act on both Gram-negative and Gram-positive bacteria.	Nakamura S, Hatanaka A	J Agric Food Chem	10.1021/jf025808c	2002	Alcohols/pharmacology, Aldehydes/pharmacology, Anti-Bacterial Agents/pharmacology, Cyclodextrins/chemistry/pharmacology, Escherichia coli/drug effects, Gases, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Kinetics, Methicillin Resistance, Odorants/analysis, Plant Leaves/chemistry, Salmonella enteritidis/drug effects, Solutions, Staphylococcus aureus/drug effects, *alpha-Cyclodextrins	Enzymology
	12476876	Interaction of iodine with 2-hydroxypropyl-alpha-cyclodextrin and its bactericidal activity.	Tomono K, Goto H, Suzuki T, Ueda H, Nagai T, Watanabe J	Drug Dev Ind Pharm	10.1081/ddc-120015359	2002	2-Hydroxypropyl-beta-cyclodextrin, Cyclodextrins/chemistry, Drug Stability, Iodine/chemistry, Microbial Sensitivity Tests, Solubility, alpha-Cyclodextrins, beta-Cyclodextrins
Enzymology	12770704	Purification and characterization of nitric oxide synthase from Staphylococcus aureus.	Hong IS, Kim YK, Choi WS, Seo DW, Yoon JW, Han JW, Lee HY, Lee HW	FEMS Microbiol Lett	10.1016/S0378-1097(03)00254-4	2003	Enzyme Inhibitors/pharmacology, Molecular Weight, NG-Nitroarginine Methyl Ester/pharmacology, Nitric Oxide Synthase/chemistry/isolation & purification/metabolism, Staphylococcus aureus/*enzymology	Phylogeny
Pathogenicity	12956062	Application of the Barton photochemical reaction in the synthesis of 1-dethia-3-aza-1-carba-2-oxacephem: a novel agent against resistant pathogenic microorganisms.	Hakimelahi GH, Li PC, Moosavi-Movahedi AA, Chamani J, Khodarahmi GA, Ly TW, Valiyev F, Leong MK, Hakimelahi S, Shia KS, Chao I	Org Biomol Chem	10.1039/b304167k	2003	Anti-Infective Agents/chemical synthesis/chemistry/pharmacology, Cell Division/drug effects, Cells, Cultured, Cephalosporins/chemical synthesis/chemistry/pharmacology, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/chemistry, Drug Resistance, Bacterial, Enzyme Inhibitors/chemistry/pharmacology, Escherichia coli/drug effects/enzymology/genetics, Humans, Isomerism, Klebsiella pneumoniae/drug effects/genetics, Methicillin/pharmacology, Microbial Sensitivity Tests, Models, Molecular, Pseudomonas aeruginosa/drug effects/enzymology/genetics, Staphylococcus aureus/*drug effects/enzymology/genetics, beta-Lactamase Inhibitors, beta-Lactams/chemistry/pharmacology	Enzymology
Pathogenicity	14529966	A kinetic microplate method for quantifying the antibacterial properties of biological fluids.	Holowachuk SA, Bal'a MF, Buddington RK	J Microbiol Methods	10.1016/s0167-7012(03)00190-8	2003	Animals, Anti-Bacterial Agents/pharmacology, Area Under Curve, Escherichia coli/drug effects/growth & development, Extracellular Fluid/chemistry/metabolism, Gentamicins/*pharmacology, Lactobacillus/drug effects/growth & development, Microbial Sensitivity Tests, Pancreas/metabolism, Staphylococcus aureus/drug effects/growth & development, Swine	Metabolism
Pathogenicity	14758005	Diastereomeric selective effects for growth inhibition of synthesized mini parallel double-stranded peptides on Escherichia coli and Staphylococcus aureus.	Kobayashi S, Atuchi N, Kobayashi H, Shiraishi A, Hamashima H, Tanaka A	Chem Pharm Bull (Tokyo)	10.1248/cpb.52.204	2004	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacokinetics/pharmacology, Cell Line, Tumor, Cell Membrane Permeability/drug effects, Circular Dichroism, Escherichia coli/drug effects/growth & development, Humans, Microbial Sensitivity Tests, Models, Molecular, Molecular Structure, Peptides/chemical synthesis/chemistry/pharmacokinetics/pharmacology, Staphylococcus aureus/drug effects/growth & development, Stereoisomerism, Structure-Activity Relationship	Enzymology
Metabolism	15028958	Nonparallel secretion of antibacterial activity and protein in porcine pancreatic juice.	Holowachuk SA, Bal'a MF, Gerard PD, Buddington RK	Pancreas	10.1097/00006676-200403000-00017	2004	Animals, Anti-Bacterial Agents/pharmacology, Eating, Enzymes/metabolism, Pancreatic Juice/*metabolism, Staphylococcus aureus/drug effects, Swine	Enzymology
Pathogenicity	15129996	Microbiological assay for enrofloxacin injection.	e Souza MJ, Bittencourt CF, e Souza Filho Pda S	Int J Pharm	10.1016/j.ijpharm.2003.11.012	2004	Anti-Bacterial Agents/pharmacology/standards, Colony Count, Microbial/methods, Enrofloxacin, Fluoroquinolones/pharmacology/standards, Injections, Quinolones/pharmacology/standards, Reference Standards, Reproducibility of Results, Sensitivity and Specificity, Staphylococcus aureus/*drug effects/growth & development
Pathogenicity	15804533	Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems.	Hakimelahi GH, Moosavi-Movahedi AA, Saboury AA, Osetrov V, Khodarahmi GA, Shia KS	Eur J Med Chem	10.1016/j.ejmech.2004.11.002	2005	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Carbapenems/chemical synthesis/chemistry/pharmacology, Drug Design, Enzyme Inhibitors/chemical synthesis/chemistry/pharmacology, Molecular Structure, Prodrugs/chemical synthesis/chemistry/*pharmacology, beta-Lactamase Inhibitors, beta-Lactamases/metabolism	Metabolism
Pathogenicity	16358986	Phagocytic and bactericidal activity and morphological parameters of blood platelets in patients with Trichinella spiralis infection.	Matowicka-Karna J, Kemona H, Dymicka-Piekarska V, Butkiewicz A	Rocz Akad Med Bialymst		2005	Adult, Aged, Animals, Antiparasitic Agents/therapeutic use, Blood Bactericidal Activity/physiology, Blood Platelets/immunology, Case-Control Studies, Female, Humans, Male, Middle Aged, Phagocytosis/physiology, Platelet Activation, Trichinella spiralis/pathogenicity, Trichinellosis/drug therapy/*immunology
Pathogenicity	16410969	Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination.	Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TC	Mem Inst Oswaldo Cruz	10.1590/s0074-02762005000700018	2006	Agar, Anti-Bacterial Agents/therapeutic use, Candida albicans/drug effects, Culture Media, Drug Evaluation, Preclinical, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/drug effects, Lactones/therapeutic use, Microbial Sensitivity Tests/methods, Physalis, Plant Extracts/pharmacology, Secosteroids, Steroids/*therapeutic use	Cultivation
Pathogenicity	16427259	Multifactorial aspects of antimicrobial activity of propolis.	Scazzocchio F, D'Auria FD, Alessandrini D, Pantanella F	Microbiol Res	10.1016/j.micres.2005.12.003	2006	Anti-Bacterial Agents/pharmacology, Ethanol/pharmacology, Microbial Sensitivity Tests, Propolis/pharmacology, Staphylococcus aureus/*drug effects/growth & development
Pathogenicity	16651758	Synthesis and biological properties of gemini quaternary ammonium compounds, 5,5'-[2,2'-(alpha,omega-polymethylnedicarbonyldioxy)diethyl]bis-(3-alkyl-4-methyl thiazolium iodide) and 5,5'-[2,2'-(p-phenylenedicarbonyldioxy)diethyl]bis(3-alkyl-4-methylthiazolium bromide).	Shirai A, Sumitomo T, Yoshida M, Kaimura T, Nagamune H, Maeda T, Kourai H	Chem Pharm Bull (Tokyo)	10.1248/cpb.54.639	2006	Alkylation, Anti-Bacterial Agents/chemical synthesis/pharmacology, Anti-Infective Agents/chemical synthesis/pharmacology, Antifungal Agents/chemical synthesis/pharmacology, Chemical Phenomena, Chemistry, Physical, Chromatography, Thin Layer, Escherichia coli/drug effects, Fungi/drug effects, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Quaternary Ammonium Compounds/chemical synthesis/pharmacology, Staphylococcus aureus, Structure-Activity Relationship, Thiazoles/chemical synthesis/*pharmacology, Yeasts/drug effects
Pathogenicity	17927050	The mechanism of the bactericidal activity of hinokitiol.	Morita Y, Sakagami Y, Okabe T, Ohe T, Inamori Y, Ishida N	Biocontrol Sci	10.4265/bio.12.101	2007	Adenine/metabolism, Anti-Infective Agents/pharmacology, Cell Membrane Permeability/drug effects, Escherichia coli/drug effects/growth & development/metabolism, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Monoterpenes/pharmacology, Oxygen Consumption/drug effects, Staphylococcus aureus/drug effects/growth & development/metabolism, Tropolone/*analogs & derivatives/pharmacology	Metabolism
Pathogenicity	18041957	Antibacterial activity of guava (Psidium guajava L.) and Neem (Azadirachta indica A. Juss.) extracts against foodborne pathogens and spoilage bacteria.	Mahfuzul Hoque MD, Bari ML, Inatsu Y, Juneja VK, Kawamoto S	Foodborne Pathog Dis	10.1089/fpd.2007.0040	2007	Anti-Bacterial Agents/pharmacology, Azadirachta/chemistry, Colony Count, Microbial, Dose-Response Relationship, Drug, Ethanol, Food Microbiology, Food Preservation/methods, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Humans, Hydrogen-Ion Concentration, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Psidium/*chemistry, Species Specificity, Temperature	Biotechnology
Biotechnology	18554739	Interactions in dual species biofilms between Listeria monocytogenes EGD-e and several strains of Staphylococcus aureus.	Rieu A, Lemaitre JP, Guzzo J, Piveteau P	Int J Food Microbiol	10.1016/j.ijfoodmicro.2008.05.006	2008	Bacterial Adhesion/physiology, Biofilms/growth & development, Colony Count, Microbial, Equipment Contamination/prevention & control, Food Contamination/prevention & control, Food Microbiology, Food-Processing Industry, Listeria monocytogenes/physiology, Microscopy, Electron, Scanning, Species Specificity, Stainless Steel, Staphylococcus aureus/*physiology	Phylogeny
Metabolism	18797139	No relationship exists between PBP 2a amounts expressed in different MRSA strains obtained clinically and their beta-lactam MIC values.	Parvez MA, Shibata H, Nakano T, Niimi S, Fujii N, Arakaki N, Higuti T	J Med Invest	10.2152/jmi.55.246	2008	Bacterial Proteins/analysis/genetics/metabolism, Humans, Immunoblotting, In Vitro Techniques, Methicillin Resistance, Methicillin-Resistant Staphylococcus aureus/drug effects/genetics/isolation & purification/metabolism, Microbial Sensitivity Tests, Penicillin-Binding Proteins/analysis/genetics/metabolism, Species Specificity, Staphylococcal Infections/drug therapy/microbiology, beta-Lactams/administration & dosage/*pharmacology	Pathogenicity
Pathogenicity	19344741	Development and validation of a microbiological agar assay for determination of cefuroxime sodium in pharmaceutical preparations.	Schmidt CA, Agarrayua DA, Laporta LV, Machado JC, Manfio ML, Bittencourt CF	J Microbiol Methods	10.1016/j.mimet.2009.03.012	2009	Agar/analysis, Anti-Bacterial Agents/pharmacology, Cefuroxime/pharmacology, Microbial Sensitivity Tests, Microbiological Techniques, Pharmaceutical Preparations/analysis, Staphylococcus aureus/drug effects
Pathogenicity	19664066	Lethal effect of chitosan-Ag (I) films on Staphylococcus aureus as evaluated by electron microscopy.	Diaz-Visurraga J, Garcia A, Cardenas G	J Appl Microbiol	10.1111/j.1365-2672.2009.04447.x	2009	Anti-Infective Agents/chemistry/pharmacology, Bacteriolysis, Cell Wall/ultrastructure, Chitosan/chemistry/pharmacology, Microbial Sensitivity Tests, Microscopy, Electron, Silver/chemistry/pharmacology, Staphylococcus aureus/drug effects/ultrastructure
Pathogenicity	20490884	Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus.	Guinoiseau E, Luciani A, Rossi PG, Quilichini Y, Ternengo S, Bradesi P, Berti L	Eur J Clin Microbiol Infect Dis	10.1007/s10096-010-0943-x	2010	Anti-Bacterial Agents/isolation & purification/pharmacology, Asteraceae/chemistry, Cell Membrane/drug effects/ultrastructure, Cell Wall/drug effects/ultrastructure, Humans, Inula/chemistry, Microbial Sensitivity Tests, Microbial Viability/drug effects, Microscopy, Electron, Transmission, Oils, Volatile/isolation & purification/pharmacology, Staphylococcus aureus/*drug effects/ultrastructure, Time Factors	Enzymology
Phylogeny	20513963	Isolation of bacteriocin-like substances producing bacteria from finished cattle-manure compost and activity evaluation against some food-borne pathogenic and spoilage bacteria.	Abdel-Mohsein H, Yamamoto N, Otawa K, Tada C, Nakai Y	J Gen Appl Microbiol	10.2323/jgam.56.151	2010	Animals, Anti-Bacterial Agents/pharmacology, Bacteriocins/biosynthesis/pharmacology, Cattle, Enterobacteriaceae/classification/drug effects/pathogenicity, Food Contamination, Food Microbiology, Gram-Positive Cocci/classification/drug effects/pathogenicity, Manure, Microbial Sensitivity Tests, Salmonella/classification/drug effects/isolation & purification/metabolism, Shigella/classification/drug effects/isolation & purification/metabolism, Soil	Pathogenicity
Pathogenicity	20562272	Direct observation and analysis of bacterial growth on an antimicrobial surface.	Yamada H, Takahashi N, Okuda S, Tsuchiya Y, Morisaki H	Appl Environ Microbiol	10.1128/AEM.00576-10	2010	Cell Cycle/drug effects, Culture Media/chemistry, Disinfectants/pharmacology, Escherichia coli/drug effects/growth & development/metabolism, Microbial Sensitivity Tests/methods, Staphylococcus aureus/drug effects/growth & development/metabolism	Metabolism
Pathogenicity	20584079	In vitro effect of branch extracts of Juniperus species from Turkey on Staphylococcus aureus biofilm.	Marino A, Bellinghieri V, Nostro A, Miceli N, Taviano MF, Guvenc A, Bisignano G	FEMS Immunol Med Microbiol	10.1111/j.1574-695X.2010.00705.x	2010	Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Biofilms/drug effects, Biomass, Chromatography, Thin Layer, Colony Count, Microbial, Juniperus/chemistry, Microbial Sensitivity Tests, Microbial Viability/drug effects, Plant Extracts/chemistry/isolation & purification/pharmacology, Spectrophotometry, Staphylococcus aureus/*drug effects/physiology, Turkey	Enzymology
Pathogenicity	20686274	Antibacterial activity of 5-dialkylaminomethylhydantoins and related compounds.	Fujisaki F, Shoji K, Shimodouzono M, Kashige N, Miake F, Sumoto K	Chem Pharm Bull (Tokyo)	10.1248/cpb.58.1123	2010	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Escherichia coli/drug effects, Hydantoins/chemical synthesis/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Staphylococcus aureus/drug effects, Stereoisomerism
Pathogenicity	20798583	Antimicrobial activities of 1,4-benzoquinones and wheat germ extract.	Kim MH, Jo SH, Ha KS, Song JH, Jang HD, Kwon YI	J Microbiol Biotechnol	10.4014/jmb.1004.04037	2010	Anti-Bacterial Agents/chemistry/pharmacology, Bacteria/drug effects, Benzoquinones/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Plant Extracts/chemistry/pharmacology, Triticum/chemistry
Metabolism	20938718	Antibacterial effect of silver nanoparticles on Staphylococcus aureus.	Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, Chen YB	Biometals	10.1007/s10534-010-9381-6	2010	Acetyltransferases/metabolism, Anti-Bacterial Agents/chemistry/pharmacology, Cell Wall/drug effects, Dose-Response Relationship, Drug, Glycerolphosphate Dehydrogenase/antagonists & inhibitors/metabolism, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Oxidoreductases/antagonists & inhibitors/metabolism, Proteomics, Recombinases/antagonists & inhibitors/metabolism, Silver/chemistry/pharmacology, Staphylococcus aureus/cytology/drug effects/enzymology	Enzymology
Pathogenicity	21652210	A concise synthesis and antimicrobial activities of 3-polyamino-23,24-bisnorcholanes as steroid-polyamine conjugates.	Kim HS, Khan SN, Jadhav JR, Jeong JW, Jung K, Kwak JH	Bioorg Med Chem Lett	10.1016/j.bmcl.2011.05.048	2011	Anti-Infective Agents/chemical synthesis/chemistry/pharmacology, Cholanes/chemical synthesis/chemistry/pharmacology, Gram-Positive Bacteria/*drug effects, Humans, Microbial Sensitivity Tests, Polyamines/chemical synthesis/chemistry/pharmacology, Structure-Activity Relationship
	22059662	Effect of chitosan in meat preservation.	Darmadji P, Izumimoto M	Meat Sci	10.1016/0309-1740(94)90114-7	1994
Pathogenicity	22736550	Enhanced photoinactivation of Staphylococcus aureus with nanocomposites containing plasmonic particles and hematoporphyrin.	Khlebtsov BN, Tuchina ES, Khanadeev VA, Panfilova EV, Petrov PO, Tuchin VV, Khlebtsov NG	J Biophotonics	10.1002/jbio.201200079	2012	Gold/chemistry, Hematoporphyrins/chemistry, Light, Metal Nanoparticles/chemistry, Microbial Viability/radiation effects, Nanocomposites/chemistry, Optical Phenomena, Photosensitizing Agents/chemistry/pharmacology, Porosity, Silicon Dioxide/chemistry, Silver/chemistry, Staphylococcus aureus/drug effects/physiology/*radiation effects, Temperature
Pathogenicity	23928379	Antimicrobial activity of quinoxaline 1,4-dioxide with 2- and 3-substituted derivatives.	Vieira M, Pinheiro C, Fernandes R, Noronha JP, Prudencio C	Microbiol Res	10.1016/j.micres.2013.06.015	2013	Anti-Infective Agents/chemistry/pharmacology, Candida albicans/drug effects, Escherichia coli/drug effects, Microbial Sensitivity Tests, Microbial Viability/drug effects, Quinoxalines/chemistry/pharmacology, Saccharomyces cerevisiae/drug effects, Staphylococcus aureus/drug effects
Pathogenicity	24053648	Developing a microbiological growth inhibition screening assay for the detection of 27 veterinary drugs from 13 different classes in animal feedingstuffs.	Bohn T, Pellet T, Boscher A, Hoffmann L	Food Addit Contam Part A Chem Anal Control Expo Risk Assess	10.1080/19440049.2013.832400	2013	Animal Feed/analysis, Animals, Anti-Bacterial Agents/analysis, Cattle, Coccidiostats/analysis, Disk Diffusion Antimicrobial Tests/methods, Drug Residues, European Union, Reproducibility of Results, Sheep, Swine, Veterinary Drugs/*analysis
Pathogenicity	24528382	Evaluation of antibacterial and cytotoxic effects of nano-sized bioactive glass/collagen composites releasing tetracycline hydrochloride.	Rivadeneira J, Di Virgilio AL, Audisio MC, Boccaccini AR, Gorustovich AA	J Appl Microbiol	10.1111/jam.12476	2014	Anti-Bacterial Agents/chemistry/pharmacology, Biocompatible Materials/chemistry/pharmacology, Body Fluids, Cell Line, Tumor, Collagen/chemistry, Glass/chemistry, Humans, Nanocomposites/chemistry, Osteoblasts/drug effects, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Tetracycline/pharmacology
Pathogenicity	24848589	Antimicrobial effect of Dinoponera quadriceps (Hymenoptera: Formicidae) venom against Staphylococcus aureus strains.	Lima DB, Torres AF, Mello CP, de Menezes RR, Sampaio TL, Canuto JA, da Silva JJ, Freire VN, Quinet YP, Havt A, Monteiro HS, Nogueira NA, Martins AM	J Appl Microbiol	10.1111/jam.12548	2014	Animals, Ant Venoms/pharmacology, Anti-Bacterial Agents/pharmacology, Ants, Staphylococcus aureus/*drug effects
Pathogenicity	24881665	Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.	Kimura M, Shindo M, Moriizumi T, Tagawa N, Fujinami A, Kato I, Uchida Y	Chem Pharm Bull (Tokyo)	10.1248/cpb.c14-00103	2014	Dose-Response Relationship, Drug, Gram-Positive Bacteria/drug effects, Humans, Intercellular Signaling Peptides and Proteins/chemistry/pharmacology, Microbial Sensitivity Tests, Protein Conformation, Structure-Activity Relationship
Pathogenicity	24907739	Antibacterial performance of ZnO-based fillers with mesoscale structured morphology in model medical PVC composites.	Machovsky M, Kuritka I, Bazant P, Vesela D, Saha P	Mater Sci Eng C Mater Biol Appl	10.1016/j.msec.2014.04.034	2014	Anti-Bacterial Agents/chemistry/pharmacology, Composite Resins/chemistry, Escherichia coli/drug effects, Polyvinyl Chloride/chemistry, Staphylococcus aureus/drug effects, Zinc Oxide/*chemistry
Pathogenicity	25353630	TLR2 activation in corneal stromal cells by Staphylococcus aureus-induced keratitis.	Marino A, Pergolizzi S, Lauriano ER, Santoro G, Spataro F, Cimino F, Speciale A, Nostro A, Bisignano G	APMIS	10.1111/apm.12333	2014	Animals, Cell Differentiation, Corneal Keratocytes/cytology, Corneal Stroma/cytology/microbiology/pathology, Enzyme Activation, Inflammation/immunology/microbiology, Interleukin-8/biosynthesis/genetics/metabolism, Keratitis/immunology/microbiology, Myofibroblasts/cytology, Organ Culture Techniques, RNA, Messenger/biosynthesis, Rabbits, Staphylococcal Infections/immunology/microbiology, Staphylococcus aureus/immunology, Stromal Cells/immunology, Toll-Like Receptor 2/biosynthesis/genetics/*immunology	Metabolism
	25523046	Synthesis, characterization, optical and antimicrobial studies of polyvinyl alcohol-silver nanocomposites.	Mahmoud KH	Spectrochim Acta A Mol Biomol Spectrosc	10.1016/j.saa.2014.11.074	2014	Anti-Infective Agents/chemical synthesis/chemistry, Aspergillus niger, Bacillus subtilis, Carbon/chemistry, Escherichia coli, Metal Nanoparticles/chemistry, Microbial Sensitivity Tests, Microscopy, Electron, Transmission, Nanocomposites/chemistry, Nanotechnology, Optics and Photonics, Particle Size, Polyvinyl Alcohol/chemistry, Pseudomonas aeruginosa, Refractometry, Silver/*chemistry, Spectrophotometry, Infrared, Staphylococcus aureus
Pathogenicity	26414807	Synthesis, characterization, crystal structure determination and biological screening of novel N-1 and C5 alkyl substituted scaffolds of pyrimidine.	Pathan NB, Parvez A, Bader A, Shaheen U, Hadda TB	Eur J Med Chem	10.1016/j.ejmech.2013.12.036	2014	Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Crystallography, X-Ray, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Escherichia coli/drug effects, Microbial Sensitivity Tests, Molecular Structure, Pyrimidines/chemistry/pharmacology, Salmonella/drug effects, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Structure-Activity Relationship
Genetics	26564052	Complete Genome Sequence of the Drug-Naive Classical Staphylococcus aureus Strain FDA209P.	Singh M, Sasaki T, Matsuo M, Morimoto Y, Aiba Y, Hiramatsu K	Genome Announc	10.1128/genomeA.01343-15	2015		Pathogenicity
Pathogenicity	26664112	Green synthesis of silver nanoparticles using cranberry powder aqueous extract: characterization and antimicrobial properties.	Ashour AA, Raafat D, El-Gowelli HM, El-Kamel AH	Int J Nanomedicine	10.2147/IJN.S87268	2015	Animals, Anti-Infective Agents/pharmacology, Bacteria/drug effects/ultrastructure, Gels/pharmacology, Green Chemistry Technology/methods, Male, Metal Nanoparticles/chemistry/ultrastructure, Microbial Sensitivity Tests, Particle Size, Plant Extracts/chemistry/pharmacology, Poloxamer/pharmacology, Powders, Rats, Silver/chemistry, Spectrophotometry, Ultraviolet, Spectroscopy, Fourier Transform Infrared, Static Electricity, Vaccinium macrocarpon/chemistry, Wound Healing/drug effects
Biotechnology	26770255	In Vitro Antimicrobial Activity and Effect on Biofilm Production of a White Grape Juice (Vitis vinifera) Extract.	Filocamo A, Bisignano C, Mandalari G, Navarra M	Evid Based Complement Alternat Med	10.1155/2015/856243	2015
Pathogenicity	27043217	Laxitextines A and B, Cyathane Xylosides from the Tropical Fungus Laxitextum incrustatum.	Mudalungu CM, Richter C, Wittstein K, Abdalla MA, Matasyoh JC, Stadler M, Sussmuth RD	J Nat Prod	10.1021/acs.jnatprod.5b00950	2016	Animals, Anti-Bacterial Agents/chemistry/isolation & purification/pharmacology, Antineoplastic Agents/chemistry/isolation & purification/pharmacology, Bacillus subtilis/drug effects, Diterpenes/chemistry/isolation & purification/pharmacology, Drug Screening Assays, Antitumor, Female, Glycosides/chemistry/isolation & purification/pharmacology, Humans, MCF-7 Cells, Methicillin Resistance/drug effects, Mice, Molecular Structure, Nuclear Magnetic Resonance, Biomolecular, Staphylococcus aureus/drug effects	Enzymology
	27247773	The application of alkaline and acidic electrolyzed water in the sterilization of chicken breasts and beef liver.	Shimamura Y, Shinke M, Hiraishi M, Tsuchiya Y, Masuda S	Food Sci Nutr	10.1002/fsn3.305	2015
Pathogenicity	27400878	Antimicrobial and anti-Quorum Sensing activities of selected medicinal plants of Ethiopia: Implication for development of potent antimicrobial agents.	Bacha K, Tariku Y, Gebreyesus F, Zerihun S, Mohammed A, Weiland-Brauer N, Schmitz RA, Mulat M	BMC Microbiol	10.1186/s12866-016-0765-9	2016	Anti-Infective Agents/isolation & purification/pharmacology, Bacillus cereus/drug effects, Bacteria/drug effects, Biofilms/drug effects, Candida albicans/drug effects, Drug Resistance, Microbial, Escherichia coli/drug effects, Ethiopia, Fruit/chemistry, Fungi/drug effects, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Plants, Medicinal/chemistry, Pseudomonas aeruginosa/drug effects, Quorum Sensing/drug effects, Seeds/chemistry, Staphylococcus aureus/drug effects, Tracheophyta/chemistry	Enzymology
Pathogenicity	27855063	In Vitro Tolerance of Drug-Naive Staphylococcus aureus Strain FDA209P to Vancomycin.	Singh M, Matsuo M, Sasaki T, Morimoto Y, Hishinuma T, Hiramatsu K	Antimicrob Agents Chemother	10.1128/AAC.01154-16	2017	Anti-Bacterial Agents/pharmacology, Isoleucine-tRNA Ligase/antagonists & inhibitors/genetics, Microbial Sensitivity Tests, Mupirocin/pharmacology, Mutation, Polymorphism, Single Nucleotide, Staphylococcus aureus/drug effects/genetics, Vancomycin/*pharmacology, Vancomycin Resistance/genetics
	29494511	Synthesis and Effect of Hierarchically Structured Ag-ZnO Hybrid on the Surface Antibacterial Activity of a Propylene-Based Elastomer Blends.	Bazant P, Sedlacek T, Kuritka I, Podlipny D, Holcapkova P	Materials (Basel)	10.3390/ma11030363	2018
Pathogenicity	29577952	Lipid transfer protein isolated from noni seeds displays antibacterial activity in vitro and improves survival in lethal sepsis induced by CLP in mice.	Souza AA, Costa AS, Campos DCO, Batista AHM, Sales GWP, Nogueira NAP, Alves KMM, Coelho-de-Souza AN, Oliveira HD	Biochimie	10.1016/j.biochi.2018.03.011	2018	Animals, Anti-Bacterial Agents/administration & dosage/chemistry, Carrier Proteins/administration & dosage/genetics/isolation & purification, Cecum/pathology/surgery, Disease Models, Animal, Humans, Lipids/chemistry/genetics, Male, Mice, Morinda/chemistry, Seeds/chemistry, Sepsis/drug therapy/microbiology/pathology/surgery, Staphylococcus aureus/drug effects/pathogenicity	Enzymology
Phylogeny	30141597	[Identification and Antagonistic Properties of the Soil Streptomycete Streptomyces sp. 100].	Biliavska LA, Efimenko TA, Efremenkova OV, Koziritska VY, Iutynska GA	Mikrobiol Z		2016	Antibiosis, Fusarium, Pseudomonas, RNA, Ribosomal, 16S/genetics, Soil, Soil Microbiology, Streptomyces/genetics/*physiology
Pathogenicity	30345828	Chemical constituents, in vitro antioxidant and antimicrobial properties of ethyl acetate extract obtained from Cytisus triflorus l'Her.	Benabderrahmane W, Amrani A, Benaissa O, Lores M, Lamas JP, de Miguel T, Benayache F, Benayache S	Nat Prod Res	10.1080/14786419.2018.1519816	2018	Acetates/chemistry, Anti-Bacterial Agents/chemistry/pharmacology, Antioxidants/administration & dosage/chemistry/pharmacology, Cytisus/chemistry, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Flavonoids/analysis/chemistry, Lipid Peroxidation/drug effects, Microbial Sensitivity Tests, Molecular Structure, Phenols/analysis, Plant Components, Aerial/chemistry, Plant Extracts/chemistry/pharmacology, Staphylococcus aureus/drug effects
Phylogeny	30509938	Genetic and Transcriptomic Analyses of Ciprofloxacin-Tolerant Staphylococcus aureus Isolated by the Replica Plating Tolerance Isolation System (REPTIS).	Matsuo M, Hiramatsu M, Singh M, Sasaki T, Hishinuma T, Yamamoto N, Morimoto Y, Kirikae T, Hiramatsu K	Antimicrob Agents Chemother	10.1128/AAC.02019-18	2019	Anti-Bacterial Agents/pharmacology, Ciprofloxacin/pharmacology, Drug Resistance, Bacterial/genetics, GTP Pyrophosphokinase/genetics, Gene Expression Profiling/methods, Humans, Leucine-tRNA Ligase/genetics, Microbial Sensitivity Tests/methods, Mupirocin/pharmacology, Staphylococcus aureus/drug effects/genetics/isolation & purification	Pathogenicity
Metabolism	30986911	Study of the Lipid Profile of ATCC and Clinical Strains of Staphylococcus aureus in Relation to Their Antibiotic Resistance.	Bisignano C, Ginestra G, Smeriglio A, La Camera E, Crisafi G, Franchina FA, Tranchida PQ, Alibrandi A, Trombetta D, Mondello L, Mandalari G	Molecules	10.3390/molecules24071276	2019	Anti-Bacterial Agents/pharmacology, Chromatography, Gas, Drug Resistance, Microbial, Fatty Acids/metabolism, Hydrophobic and Hydrophilic Interactions, Microbial Sensitivity Tests, Phospholipids/metabolism, Staphylococcus aureus/drug effects/*metabolism	Pathogenicity
Pathogenicity	31009250	Antibacterial Effects of Phytic Acid against Foodborne Pathogens and Investigation of Its Mode of Action.	Zhou QI, Zhao YU, Dang H, Tang Y, Zhang B	J Food Prot	10.4315/0362-028X.JFP-18-418	2019	Anti-Bacterial Agents/pharmacology, Bacteria/drug effects, Bacterial Adhesion/drug effects, Food Microbiology, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, *Phytic Acid/pharmacology	Biotechnology
Pathogenicity	31365649	Evaluating antimicrobial and antioxidant capacity of endemic Phlomis russeliana from Turkey and its antiproliferative effect on Human Caco-2 Cell Lines.	Alpay M, Dulger G, Sahin IE, Dulger B	An Acad Bras Cienc	10.1590/0001-3765201920180404	2019	Anti-Bacterial Agents/isolation & purification/pharmacology, Antioxidants/isolation & purification/pharmacology, Caco-2 Cells, Candida albicans/drug effects, Disk Diffusion Antimicrobial Tests, Gram-Negative Bacteria/classification/drug effects, Gram-Positive Bacteria/classification/drug effects, Humans, Phlomis/chemistry, Plant Extracts/*pharmacology, Turkey	Phylogeny
Pathogenicity	31614835	Comparative In Vitro Evaluation of Antibacterial and Osteogenic Activity of Polysaccharide and Flavonoid Fractions Isolated from the leaves of Saussurea controversa.	Khlusov I, Avdeeva E, Shupletsova V, Khaziakhmatova O, Litvinova L, Porokhova E, Reshetov Y, Zvereva I, Mushtovatova L, Karpova M, Guryev A, Sukhodolo I, Belousov M	Molecules	10.3390/molecules24203680	2019	Anti-Bacterial Agents/chemistry/pharmacology, Cell Differentiation/drug effects, Flavonoids/chemistry/pharmacology, Humans, Mesenchymal Stem Cells/drug effects, Osteogenesis/drug effects, Plant Leaves/chemistry, Polysaccharides/chemistry/pharmacology, Saussurea/chemistry	Phylogeny
Pathogenicity	31623329	The Antimicrobial and Antiviral Activity of Polyphenols from Almond (Prunus dulcis L.) Skin.	Musarra-Pizzo M, Ginestra G, Smeriglio A, Pennisi R, Sciortino MT, Mandalari G	Nutrients	10.3390/nu11102355	2019	Animals, Anti-Infective Agents/pharmacology, Antiviral Agents/pharmacology, Chlorocebus aethiops, DNA, Viral/analysis, Herpesvirus 1, Human/drug effects/genetics, Microbial Sensitivity Tests, Plant Extracts/chemistry, Polyphenols/isolation & purification/pharmacology, Prunus dulcis/chemistry, Seeds/*chemistry, Staphylococcus aureus/drug effects, Vero Cells/virology	Enzymology
Pathogenicity	32448814	Potent Antibacterial Activity of Synthetic Peptides Designed from Salusin-beta and HIV-1 Tat(49-57).	Kimura M, Kosuge K, Ko Y, Kurosaki N, Tagawa N, Kato I, Uchida Y	Chem Pharm Bull (Tokyo)	10.1248/cpb.c20-00209	2020	Amino Acid Sequence, Anti-Bacterial Agents/chemical synthesis/chemistry/pharmacology, Cell Membrane/drug effects, Escherichia coli/drug effects, HIV-1/metabolism, Humans, Intercellular Signaling Peptides and Proteins/chemistry, Microbial Sensitivity Tests, Peptides/chemical synthesis/chemistry/pharmacology, Staphylococcus aureus/drug effects, tat Gene Products, Human Immunodeficiency Virus/chemistry	Metabolism
Pathogenicity	32589001	Preparation, Antimicrobial Properties, and Cytotoxicity of Acrylic Resins Containing Poly(diallyldimethylammonium chloride).	Dos Santos RLO, Sarra G, Lincopan N, Petri DFS, Aliaga J, Marques MM, Dias RB, Coto NP, Sugaya NN, Paula CR	Int J Prosthodont	10.11607/ijp.6506	2020	Acrylic Resins, Anti-Bacterial Agents, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Polyethylenes, Quaternary Ammonium Compounds
	34219748	Bacteriostatic impact of nanoscale zero-valent iron against pathogenic bacteria in the municipal wastewater.	Sadek AH, Asker MS, Abdelhamid SA	Biologia (Bratisl)	10.1007/s11756-021-00814-w	2021
	34714443	The Ethyl Acetate Extract of the Marine Edible Gastropod Haliotis tuberculata coccinea: a Potential Source of Bioactive Compounds.	Tortorella E, Giugliano R, De Troch M, Vlaeminck B, de Vicose GC, de Pascale D	Mar Biotechnol (NY)	10.1007/s10126-021-10073-0	2021	Acetates, Animals, Bivalvia, Gastropoda, *Methicillin-Resistant Staphylococcus aureus
	34866130	Anti-Biofilm Effects of Torilis japonica Ethanol Extracts against Staphylococcus aureus.	Kim GS, Park CR, Kim JE, Kim HK, Kim BS	J Microbiol Biotechnol	10.4014/jmb.2107.07053	2022	Animals, Anti-Bacterial Agents/pharmacology, Biofilms, Ethanol/pharmacology, Methicillin-Resistant Staphylococcus aureus, Microbial Sensitivity Tests, Plant Extracts/pharmacology, Sheep, Staphylococcal Infections/drug therapy, Staphylococcus aureus
Pathogenicity	34994956	Characterization and validation of an alternative reference bacterium Korean Pharmacopoeia Staphylococcus aureus strain.	An YW, Choi YS, Yun MR, Choi C, Kim SY	J Microbiol	10.1007/s12275-022-1335-5	2022	Anti-Bacterial Agents/pharmacology, Bacterial Typing Techniques/methods, Drug Resistance, Bacterial, Humans, RNA, Ribosomal, 16S, Reference Standards, Republic of Korea, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods, Staphylococcal Infections/microbiology, Staphylococcus aureus/classification/cytology/drug effects/genetics, Whole Genome Sequencing	Phylogeny
Pathogenicity	35049890	Saccharobisindole, Neoasterric Methyl Ester, and 7-Chloro-4(1H)-quinolone: Three New Compounds Isolated from the Marine Bacterium Saccharomonospora sp.	Kim S, Le TC, Han SA, Hillman PF, Hong A, Hwang S, Du YE, Kim H, Oh DC, Cha SS, Lee J, Nam SJ, Fenical W	Mar Drugs	10.3390/md20010035	2021	Actinobacteria, Animals, Anti-Bacterial Agents/chemistry/pharmacology, Aquatic Organisms, Bacillus subtilis/drug effects, Esters, Humans, Microbial Sensitivity Tests, Quinolones/chemistry/*pharmacology	Phylogeny
	35206082	Probiotic Effects and Metabolic Products of Enterococcus faecalis LD33 with Respiration Capacity.	Jiao Y, Yang H, Shigwedha N, Zhang S, Liu F, Zhang L	Foods	10.3390/foods11040606	2022
	35478884	Development of structurally extended benzosiloxaboroles - synthesis and in vitro biological evaluation.	Pacholak P, Krajewska J, Winska P, Dunikowska J, Gogowska U, Mierzejewska J, Durka K, Wozniak K, Laudy AE, Lulinski S	RSC Adv	10.1039/d1ra04127d	2021
	36090419	Oxazoline scaffold in synthesis of benzosiloxaboroles and related ring-expanded heterocycles: diverse reactivity, structural peculiarities and antimicrobial activity.	Krajewska J, Nowicki K, Durka K, Marek-Urban PH, Winska P, Stepniewski T, Wozniak K, Laudy AE, Lulinski S	RSC Adv	10.1039/d2ra03910a	2022
Phylogeny	36289975	In Silico Study for Algerian Essential Oils as Antimicrobial Agents against Multidrug-Resistant Bacteria Isolated from Pus Samples.	Aouf A, Bouaouina S, Abdelgawad MA, Abourehab MAS, Farouk A	Antibiotics (Basel)	10.3390/antibiotics11101317	2022		Pathogenicity
	36404740	Apis mellifera Venom Inhibits Bacterial and Fungal Pathogens in vitro.	K Bakhiet E, A M Hussien H, Elshehaby M	Pak J Biol Sci	10.3923/pjbs.2022.875.884	2022	Bees, Animals, Antifungal Agents/pharmacology, Microbial Sensitivity Tests, Bacteria, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/pharmacology, Escherichia coli

Reference

@id	authors	catalogue	doi/url	title
139	Curators of the DSMZ	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 346)	https://www.dsmz.de/collection/catalogue/details/culture/DSM-346
20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.		10.1099/ijsem.0.004332	List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
41865	Curators of the CIP		https://brclims.pasteur.fr/brcWeb/souche/detail/1/17000
66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann		https://diaspora-project.de/progress.html#genomes	Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770	Curators of the JCM		https://jcm.brc.riken.jp/en/
68375				Automatically annotated from API ID32STA
68382				Automatically annotated from API zym
69479	João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.		https://microbeatlas.org/	MicrobeAtlas 1.0 beta
69480	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann		https://diaspora-project.de/progress.html#genomes	Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481	Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch		10.21203/rs.3.rs-2527258/v1	Predictions based on the model GenomeNet Sporulation v. 1
83588	Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.		10.60712/SI-ID4992.1	StrainInfo: A central database for resolving microbial strain identifiers
116632	Curators of the CIP	Collection of Institut Pasteur (CIP 53.156)	https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2053.156

@ref	URE	ADH Arg	ODC	ESC	GLU	FRU	MNE	MAL	LAC	TRE	MAN	RAF	RIB	CEL	NIT	VP	beta GAL	ArgA	PAL	PyrA	NOVO	SAC	NAG	TUR	ARA	beta GUR
139	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+/-	+	+	-	+/-	-	+	+	-	-	+	+	-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	-	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-

@ref	URE	ADH Arg	ODC	ESC	GLU	FRU	MNE	MAL	LAC	TRE	MAN	RAF	RIB	CEL	NIT	VP	beta GAL	ArgA	PAL	PyrA	NOVO	SAC	NAG	TUR	ARA	beta GUR
139	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+/-	+	+	-	+/-	-	+	+	-	-	+	+	-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	-	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-

General

NCBI tax id

strain history

Name and taxonomic classification

LPSN

synonyms

Morphology

cell morphology

colony morphology

Culture and growth conditions

culture medium

culture temp

Physiology and metabolism

oxygen tolerance

antibiogram

spore formation

metabolite utilization

metabolite production

metabolite tests

enzymes

API zym

API ID32STA

API biotype100

Isolation, sampling and environmental information

taxonmaps

Safety information

risk assessment

Sequence information

16S sequences

Genome sequences

Genome-based predictions

predictions

External links

straininfo link

literature

Reference

@ref	URE	ADH Arg	ODC	ESC	GLU	FRU	MNE	MAL	LAC	TRE	MAN	RAF	RIB	CEL	NIT	VP	beta GAL	ArgA	PAL	PyrA	NOVO	SAC	NAG	TUR	ARA	beta GUR
139	+	+	-	-	+	+	+	+	+	+	+	-	-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+/-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+/-	+	+	-	+/-	-	+	+	-	-	+	+	-	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	-	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+	-	+	+	-	-	+	+	+	+	+	-	-	-
139	+	+	-	-	+	+	+	+	+	+	+	-	+/-	-	+	+	-	-	+	+	+	+	+	-	-	-